DANALAB – Tablets

Methandrostenolone is characterized by having androgenic and anabolic properties, the main indication for these being the treatment of male hypogonadism.

Protein synthesis is increased, since it is compatible with the increase protein at the muscle level. This effect is shown in a positive nitrogen balance and an improved feeling of well-being. The balance of calcium is also positively influenced, as it promotes the deposit of calcium in the bones. Methandrostenolone is indicated for the treatment of all diseases and conditions in which an anabolic effect (increased protein synthesis) and a general strengthening effect are required.

Because this is a 17-Alkilated substance that is associated with hepatotoxicity. The following reactions require medical supervision and are common with the use of all types of testosterones:

menstrual irregularities in women, bladder irritability, gynecomastia, anaphylaxis, edema, erythrocytosis, gastrointestinal irritation, hypercalcemia and polycythemia, androgenic alopecia, seborrhea and acne in women and men.

Carcinoma prostatic hypertrophy, and increased sexual desire, cholestatic jaundice, excitability; hypercholesterolemia; hypercalcemia, edema.

In women: virilization

In men: priapism, oligospermia, hirsutism, decreased libido, decreased testicular mass, functional impotence.

Other adverse reactions are: constipation, nausea, diarrhea, infection, changes in libido, stomach pain, difficulty sleeping, headache, anxiety, depression, generalized paraesthesia, skin rash.

Hypersensitivity to Methandrostenolone.

Severe liver failure

In prepubertal individuals or people in an aggressive state;

Pregnancy, breastfeeding.

Interactions with other medications

As with testosterone and other androgens and anabolic steroids that increase the activity of certain drugs and consequently their toxicity. Among them are cyclosporine, antidiabetics, levothyroxine, anticoagulants such as warfarin.

A resistance to neuromuscular blockers has also been reported.

The tablets should be taken orally in doses of 10 mg.

Methandrostelonolone is a 17 -? - Alkilated substance associated with hepatotoxicity. Liver function must be closely monitored during treatment. It should not be administered to patients with hepatic impairment.

There is no specific antidote. Supportive measures should be taken in the event of an overdose, such as keeping the airway open and monitoring cardiovascular function.

Box with 100 tablets.

Store at a temperature below 25 ° C in a dry place.

Keep out of the reach of children.

The sale only with the prescription.